ARYA Sciences Acquisition Corp II

ARYA Sciences Acquisition Corp II, sponsored by ARYA Sciences — the SPAC vehicle of healthcare-focused investment firm Perceptive Advisors — completed its business combination with Cerevel Therapeutics in October 2020, with the combined company trading on Nasdaq under the ticker CERE. Cerevel operated as a biopharmaceutical company concentrated on neuroscience therapies targeting brain diseases. In August 2024, the company filed a Form 15-12G with the SEC to terminate its Exchange Act registration under Section 12(g), concluding its public reporting obligations following AbbVie's completed acquisition of Cerevel earlier that year. The SPAC originally launched its IPO in 2020, targeting the life sciences sector. Sign up at SpacDesk for full filing history, deal data, and sponsor-level analytics on ARYA Sciences and the broader SPAC universe.